{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:57:05Z","timestamp":1794229025638,"version":"4.9.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021ZD0114104"],"award-info":[{"award-number":["2021ZD0114104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021ZD0114105"],"award-info":[{"award-number":["2021ZD0114105"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021ZD0114101"],"award-info":[{"award-number":["2021ZD0114101"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12072-022-10410-y","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T07:03:42Z","timestamp":1662015822000},"page":"1282-1296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status"],"prefix":"10.1007","volume":"16","author":[{"given":"Guiying","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhan","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5059-3743","authenticated-orcid":false,"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"issue":"10","key":"10410_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41575-020-0296-6","volume":"17","author":"PA Revill","year":"2020","unstructured":"Revill PA, Tu T, Netter HJ, et al. The evolution and clinical impact of hepatitis B virus genome diversity. Nat Rev Gastroenterol Hepatol. 2020;17(10):618\u2013634","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10410_CR2","doi-asserted-by":"publisher","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","volume":"4","author":"MF Yuen","year":"2018","unstructured":"Yuen MF, Chen DS, Dusheiko GM, et al. Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4:18035","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10410_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/BLT.18.219469","volume":"97","author":"J Liu","year":"2019","unstructured":"Liu J, Liang W, Jing W, et al. Countdown to 2030: eliminating hepatitis B disease. China Bull World Health Organ. 2019;97(3):230\u2013238","journal-title":"China Bull World Health Organ"},{"key":"10410_CR4","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u20131858."},{"key":"10410_CR5","unstructured":"World Orgnization Health. Hepatitis B. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-b [cited 31 Dec 2021]."},{"key":"10410_CR6","unstructured":"Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Available from: http:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/ [cited 31 Dec 2021]."},{"key":"10410_CR7","unstructured":"Global health sector strategy on viral hepatitis 2016\u20132021. Geneva: World Health Organization; 2016. Available from: http:\/\/www.who.int\/hepatitis\/strategy2016-2021\/ghss-hep\/en\/ [cited 31 Dec 2021]"},{"issue":"5","key":"10410_CR8","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","volume":"49","author":"TJ Liang","year":"2009","unstructured":"Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5):S13-21","journal-title":"Hepatology"},{"issue":"22","key":"10410_CR9","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1056\/NEJM200205303462202","volume":"346","author":"AS Lok","year":"2002","unstructured":"Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346(22):1682\u20131683","journal-title":"N Engl J Med"},{"key":"10410_CR10","unstructured":"Organization WH. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/154590\/9789241549059_eng.pdf;jsessionid=C45FBB6C849F7F96F2213274A3FE2336?sequence=1. Accessed Mar 2015, 2015."},{"issue":"5","key":"10410_CR11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","volume":"44","author":"Y Tian","year":"2016","unstructured":"Tian Y, Kuo CF, Akbari O, et al. Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission. Immunity. 2016;44(5):1204\u20131214","journal-title":"Immunity"},{"issue":"1","key":"10410_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/hep.26635","volume":"59","author":"K Ito","year":"2014","unstructured":"Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59(1):89\u201397","journal-title":"Hepatology"},{"issue":"3","key":"10410_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jhep.2021.04.035","volume":"75","author":"DY Zeng","year":"2021","unstructured":"Zeng DY, Li JM, Lin S, et al. Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990\u20132019. J Hepatol. 2021;75(3):547\u2013556","journal-title":"J Hepatol"},{"issue":"4","key":"10410_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674\u2013683","journal-title":"J Hepatol"},{"issue":"10","key":"10410_CR15","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.3390\/cancers12102967","volume":"12","author":"EM Haberl","year":"2020","unstructured":"Haberl EM, Feder S, Pohl R, et al. Chemerin is induced in non-alcoholic fatty liver disease and hepatitis B-related hepatocellular carcinoma. Cancers (Basel). 2020;12(10):2967","journal-title":"Cancers (Basel)"},{"key":"10410_CR16","doi-asserted-by":"crossref","unstructured":"GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245\u2013266.","DOI":"10.1016\/S2468-1253(19)30349-8"},{"key":"10410_CR17","doi-asserted-by":"publisher","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) UHC Effective Coverage Index 1990\u20132019. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2020. https:\/\/doi.org\/10.6069\/GT4K-3B35.","DOI":"10.6069\/GT4K-3B35"},{"key":"10410_CR18","unstructured":"Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1250\u20131284."},{"key":"10410_CR19","unstructured":"WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. 2021; https:\/\/www.who.int\/publications\/i\/item\/9789240027077 [cited 12 July 2022]."},{"issue":"3","key":"10410_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.vaccine.2009.10.110","volume":"28","author":"B Hepatitis","year":"2010","unstructured":"Hepatitis B. vaccines: WHO position paper\u2013recommendations. Vaccine. 2010;28(3):589\u2013590","journal-title":"Vaccine"},{"key":"10410_CR21","unstructured":"World Health Organization. Immunization coverage. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage [cited 12 July 2022]."},{"key":"10410_CR22","unstructured":"Measuring routine childhood vaccination coverage in 204 countries and territories, 1980\u20132019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1. Lancet. 2021;398(10299):503\u2013521."},{"issue":"11","key":"10410_CR23","doi-asserted-by":"publisher","first-page":"e1491","DOI":"10.1016\/S2214-109X(21)00415-0","volume":"9","author":"OA Lesi","year":"2021","unstructured":"Lesi OA, Ward JW. Paving the way towards hepatitis B virus-free generations in Africa. Lancet Glob Health. 2021;9(11):e1491\u2013e1492","journal-title":"Lancet Glob Health"},{"issue":"27","key":"10410_CR24","first-page":"369","volume":"92","author":"B Hepatitis","year":"2017","unstructured":"Hepatitis B. vaccines: WHO position paper\u2014July 2017. Wkly Epidemiol Rec. 2017;92(27):369\u2013392","journal-title":"Wkly Epidemiol Rec"},{"key":"10410_CR25","unstructured":"World Health Organization. Practices to improve coverage of the hepatitis B birth dose vaccine, 2013. Geneva, 2013. Available at http:\/\/www.who.int\/immunization\/documents\/control\/who_ivb_12.11\/en\/. [cited 10 July 2022]."},{"issue":"11","key":"10410_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrgastro.2016.138","volume":"13","author":"JP Allain","year":"2016","unstructured":"Allain JP, Opare-Sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol. 2016;13(11):643\u2013653","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10410_CR27","unstructured":"WHO. Hepatitis B control: country profile 2020. 2021; https:\/\/www.who.int\/publications\/i\/item\/9789290616986 [cited 12 July 2022]."},{"issue":"1","key":"10410_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cld.2009.11.013","volume":"14","author":"ML Shiffman","year":"2010","unstructured":"Shiffman ML. Management of acute hepatitis B. Clin Liver Dis. 2010;14(1):75\u201391","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10410_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/oxfordjournals.aje.a114289","volume":"123","author":"RP Perrillo","year":"1986","unstructured":"Perrillo RP, Strang S, Lowry OH. Different operating conditions affect risk of hepatitis B virus infection at two residential institutions for the mentally disabled. Am J Epidemiol. 1986;123(4):690\u2013698","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10410_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","volume":"3","author":"D Razavi-Shearer","year":"2018","unstructured":"Razavi-Shearer D, Gamkrelidze I, Nguyen MH, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383\u2013403","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10410_CR31","unstructured":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022."},{"issue":"9663","key":"10410_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"YF Liaw","year":"2009","unstructured":"Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582\u2013592","journal-title":"Lancet"},{"issue":"10","key":"10410_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10003","key":"10410_CR34","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u20131555","journal-title":"Lancet"},{"key":"10410_CR35","unstructured":"NHS. Hepatitis B vaccine. https:\/\/www.nhs.uk\/conditions\/vaccinations\/hepatitis-b-vaccine\/?tabname=babies-and-toddlers. Accessed 13 Jan 2019."},{"issue":"1","key":"10410_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0272989X9301300103","volume":"13","author":"M Krahn","year":"1993","unstructured":"Krahn M, Detsky AS. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis. Med Decis Making. 1993;13(1):4\u201320","journal-title":"Med Decis Making"},{"issue":"6","key":"10410_CR37","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","volume":"72","author":"E Tr\u00e9po","year":"2020","unstructured":"Tr\u00e9po E, Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol. 2020;72(6):1196\u20131209","journal-title":"J Hepatol"},{"issue":"5","key":"10410_CR38","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","volume":"72","author":"JM Paik","year":"2020","unstructured":"Paik JM, Golabi P, Younossi Y, et al. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 2020;72(5):1605\u20131616","journal-title":"Hepatology"},{"issue":"5","key":"10410_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ajg.2012.7","volume":"107","author":"AF Carrion","year":"2012","unstructured":"Carrion AF, Martin P. Viral hepatitis in the elderly. Am J Gastroenterol. 2012;107(5):691\u2013697","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10410_CR40","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1111\/liv.12818","volume":"35","author":"JW Park","year":"2015","unstructured":"Park JW, Chen M, Colombo M, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015;35(9):2155\u20132166","journal-title":"Liver Int"},{"issue":"11","key":"10410_CR41","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/ajg.2015.289","volume":"110","author":"JD Yang","year":"2015","unstructured":"Yang JD, Gyedu A, Afihene MY, et al. Hepatocellular carcinoma occurs at an earlier age in Africans, particularly in association with chronic hepatitis B. Am J Gastroenterol. 2015;110(11):1629\u20131631","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10410_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6","journal-title":"Nat Rev Dis Primers"},{"issue":"11\u201312","key":"10410_CR43","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/apt.14352","volume":"46","author":"S Pol","year":"2017","unstructured":"Pol S, Haour G, Fontaine H, et al. The negative impact of HBV\/HCV coinfection on cirrhosis and its consequences. Aliment Pharmacol Ther. 2017;46(11\u201312):1054\u20131060","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10410_CR44","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1086\/599110","volume":"48","author":"GK Nikolopoulos","year":"2009","unstructured":"Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis. 2009;48(12):1763\u20131771","journal-title":"Clin Infect Dis"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10410-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10410-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10410-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:39:29Z","timestamp":1669513169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10410-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10410"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10410-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}